Gene: ENTPD1
Official Full Name: ectonucleoside triphosphate diphosphohydrolase 1provided by HGNC
Gene Summary: The protein encoded by this gene is a plasma membrane protein that hydrolyzes extracellular ATP and ADP to AMP. Inhibition of this protein's activity may confer anticancer benefits. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2015]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01320 | ENTPD1 Knockout cell line (HCT 116) | Human | ENTPD1 | 1:2~1:4 | Negative | Online Inquiry |
KO09915 | ENTPD1 Knockout cell line (HeLa) | Human | ENTPD1 | 1:3~1:6 | Negative | Online Inquiry |
KO09916 | ENTPD1 Knockout cell line (HEK293) | Human | ENTPD1 | 1:3~1:6 | Negative | Online Inquiry |
KO09917 | ENTPD1 Knockout cell line (A549) | Human | ENTPD1 | 1:3~1:4 | Negative | Online Inquiry |
ENTPD1 Gene Knockout Cell Lines are specialized cellular models engineered to lack the expression of the ENTPD1 gene, which encodes ecto-nucleotide triphosphate diphosphohydrolase-1 (ENPP1). This enzyme plays a crucial role in nucleotide metabolism by hydrolyzing extracellular nucleotides, thus regulating cellular signaling pathways and modulating inflammatory responses. By creating knockout variants of these cell lines, researchers can subsequently investigate the functional implications of ENTPD1 deficiency and explore its involvement in pathological conditions such as cancer, cardiovascular diseases, and neurodegenerative disorders.
The primary function of ENTPD1 Gene Knockout Cell Lines lies in facilitating the study of the downstream effects of nucleotide signaling and the resultant biochemical pathways. The absence of the ENTPD1 enzyme alters the nucleotide pool available to cells, which in turn affects purinergic signaling dynamics, thereby allowing scientists to elucidate its role in physiological and pathological processes. These cell lines provide powerful tools for studying cellular responses to stress, infection, and therapeutic interventions, enabling a deeper understanding of disease mechanisms and the development of novel therapeutic strategies.
In terms of scientific significance, these knockout cell lines serve as pivotal platforms for experimental research and drug development. They allow for the identification of potential therapeutic targets, the evaluation of drug efficacy, and the analysis of cellular metabolic pathways affected by ENTPD1 deletion. Compared to traditional cell lines that may have functional ENTPD1, our knockout models offer a unique avenue for dissecting the biological roles and therapeutic implications of nucleotide signaling.
The advantages of ENTPD1 Gene Knockout Cell Lines over alternatives include their specificity, reproducibility, and characterized genetic modification that enables greater confidence in experimental outcomes. Researchers will find these models particularly valuable as they advance their studies into the diverse biological roles of extracellular nucleotides and the associated therapeutic potentials.
With a commitment to cutting-edge science, our company specializes in providing high-quality biological products and innovative tools tailored for research applications. By leveraging our expertise in cellular engineering and molecular biology, we ensure that our products meet the rigorous demands of researchers and clinicians striving to advance their understanding of complex biological phenomena.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.